PROGRESS IN UREMIC TOXIN RESEARCH: Uremic Toxins in Acute Kidney Injury
Authors:
- 1 July 2009
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 22 (4) , 445-448
Abstract
Acute kidney injury (AKI) is a serious and frequent condition which may fully resolve but is associated with markedly increased mortality. Mortality in AKI is caused by nonrenal, distant organ failure. Renal recovery from AKI is often not achieved on account of new injuries in the repair phase. Uremic toxins may be the missing link between AKI and nonrenal organ failure, tubular and endothelial injury. Compared with chronic kidney disease (CKD), research of uremic toxins in AKI is in its infancy. This review presents the current knowledge on uremic toxins in AKI which is predominately derived from experimental studies. Most uremic toxins investigated have previously been identified in CKD. The review focuses on those uremic toxins with biologic effect on the respective nonrenal organs failing in AKI and on the renal tubule and the endothelium. These uremic toxins may insofar be specific mediators of pathophysiological processes in AKI.Keywords
This publication has 42 references indexed in Scilit:
- Intensity of Renal Support in Critically Ill Patients with Acute Kidney InjuryNew England Journal of Medicine, 2008
- Acute Kidney Injury Leads to Inflammation and Functional Changes in the BrainJournal of the American Society of Nephrology, 2008
- What is new in uremic toxicity?Pediatric Nephrology, 2008
- Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal functionKidney International, 2007
- Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill childrenCritical Care, 2007
- Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced qacute renal failureKidney International, 2007
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Acute renal failureThe Lancet, 2005
- Low dialysance of asymmetric dimethylarginine (ADMA) - in vivo and in vitro evidence of significant protein bindingClinical Nephrology, 2004
- Plasma leptin concentration in patients with acute renal failureClinical Nephrology, 2004